Home » Prescription Drugs 7 » Femodene Generic Gestodene
FEMODENE 28: The memo-pack holds 21 white tablets diameter 5.7 mm containing 0.075 mg gestodene and 0.030 mg ethinylestradiol and in addition 7 larger white non-hormonal tablets diameter 6.8 mm.Indications:Oral contraceptionDosage and Administration:Combined oral contraceptives such as FEMODENE 28 when taken correctly have a failure rate of approximately 1% per year. The failure rate may increase when pills are missed or taken incorrectly.How to Take FEMODENE 28:Tablets must be taken in the order directed on the package every day at about the same time with some water as needed. Tablet-taking is continuous. One tablet is to be taken daily for 28 consecutive days. Each subsequent pack is started the day after the last tablet of the previous pack following the directional arrows. Withdrawal bleeding usually occurs while taking the 7 non-hormonal tablets. This usually starts on day 2 - 3 after starting the non-hormonal tablets and may not have finished before the next pack is started.How to Start FEMODENE 28:START WITH THE FIRST TABLET FROM THE GREEN SECTION MARKED WITH THAT DAY OF THE WEEK in accordance with one of the following:No preceding hormonal contraceptive use (in the past month) Tablet taking has to start on day 1 of the woman's natural cycle (i.e. the first day of her menstrual bleeding). Starting on days 2 - 3 is allowed but during the first cycle an additional barrier contraceptive method is recommended for the first 7 days of tablet taking.Changing from another combined oral contraceptive (COC) vaginal ring or transdermal patch The woman should start with FEMODENE 28 preferably on the day after the last hormonal tablet of her previous COC but at the latest on the day following the usual tablet-free or non-hormonal tablet interval of her previous COC.In case a vaginal ring or transdermal patch has been used the woman should start using FEMODENE 28 preferably on the day of removal but at the latest when the next application would have been due.Changing from a progestogen-only method (minipill injection implant) or progestogen-releasing intrauterine system (IUS) The woman may switch any day from the minipill from an implant or IUS on the day of its removal or from an injectable when the next injection would be due. In all of these cases the woman should be advised to additionally use a barrier contraceptive method for the first 7 days of tablet taking.Following first-trimester abortion The woman may start immediately. When doing so she need not take additional contraceptive measures.Following delivery or second-trimester abortion The woman should be advised to start at day 21 to 28 after delivery or second-trimester abortion. When starting later than this the woman should be advised to additionally use a barrier contraceptive method for the first 7 days of tablet taking. However if intercourse has already occurred pregnancy should be excluded before starting FEMODENE 28 or the woman has to wait for her first menstrual period.Management of Missed TabletsErrors in taking the non-hormonal tablets contained in FEMODENE 28 can be ignored. However they should be discarded to avoid unintentionally prolonging the placebo tablet phase. The following advice only refers to missed non-hormonal tablets:If the user is less than 12 hours late in taking any hormonal tablet contraceptive protection is not reduced. The woman should take the tablet as soon as she remembers and should take subsequent tablets at the usual time.If she is more than 12 hours late in taking any hormonal tablet contraceptive protection may be reduced.There is a particularly high risk of pregnancy if tablets are missed just before or immediately after taking the non-hormonal tablets. If tablets are missed in the first week of taking hormonal tablets following the non-hormonal tablets and intercourse took place in the preceding 7 days the possibility of pregnancy should be considered.The management of missed tablets can be guided by the following two basic rules:Tablet taking must never be discontinued for longer than 7 days. Seven days of uninterrupted tablet taking are required to attain adequate suppression of the hypothalamic-pituitary-ovarian axis. These rules form the basis of the instructions to patients provided in the package insert.
Buy Femodene Generic Gestodene and other Prescription Drugs 7 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Femodene Generic Gestodene:
Product Type: Prescription Drugs 7
Femodene ( Generic Gestodene/Ethinylestradiol )
Femodene (Generic Gestodene/Ethinylestradiol)
Generic Gestodene/Ethinylestradiol
0.075/0.030mg 84(3 x 28) Tablets 168(6 x 28) Tablets
Generic Gestodene/Ethinylestradiol Femodene

View more
Prescription Drugs 7
Previous Product Next Product
Prescription Free Drugs:
Information about cheap medication from Med Store - Very large generic medication selection; Everyday low medication prices; 20% free bonus pills for all refills and reorders; Strict medication quality standards; Free doctor consultations.
MedStore guarantees delivery of your medication. If your order is not received, please let us know, and we will reship it FOR FREE.
If for any reason, you feel that you are not completely satisfied with your order we will reship your order for free or will issue a full refund back to your credit card.
Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease, or prescribing any medication. You should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your doctor.
Thank you for visiting the MedStore Web site (the “Site”). MedStore is a leading online drugstore: a retail store and information site for health, beauty, wellness, personal care and pharmacy products. The Site is designed to provide a convenient, private and informative shopping experience for consumers to purchase products essential to healthy, everyday living. Accessible 24 hours a day, 7 days a week, the MedStore online store offers a larger selection of products than typical store-based retailers, along with a wealth of health-related information, buying guides and other tools designed to help consumers make educated purchasing decisions. EximStar WorldWide Ltd and its subsidiaries and affiliates (“we, us, our”) want each visitor to the Site (“you”) to have a safe, pleasurable visit, so we have established the following terms and conditions so that we (we and you) know what to expect from each other. By using the Site you agree to be bound by the terms set forth herein. We may make changes to the Site,
these Terms of Use, or the policies and conditions that govern the use of the Site at any time. We encourage you to review the Site and these terms periodically for any updates or changes. Your continued access or use of the Site shall be deemed your acceptance of these changes and the reasonableness of these standards for notice of changes.
Medicine News : The first transgenic mouse model of a rare and severe type of autism called Timothy Syndrome is improving the scientific understanding of autism spectrum disorder in general and may help researchers design more targeted interventions and treatments. The research is described in a paper published last week by scientists at the University at Buffalo and Stanford University in the Proceedings of the National Academy of Sciences.
The transgenic mouse developed at UB exhibits the repetitive physical behaviors, altered social behaviors and impaired communication abilities associated not just with Timothy Syndrome but with autism spectrum disorder in general.
The fact that this mouse exhibited so many behavioral parallels with humans diagnosed with autism was both surprising and encouraging, the researchers say.
"This animal and the syndrome that it is associated with, provides one of the best chances to understand the underlying mechanisms of autism," says Randall L. Rasmusson, PhD, professor of physiology and biophysics in the UB School of Medicine and Biomedical Sciences and co-author on the PNAS paper.
Femara (Letrozole)
FEMILON Apri
Femodene Generic Gestodene
FENOLIP Antara
FENOXENE Dibenzyline
Fentoin ER Dilantin
FERTOMID Clomid
Fexigra Allegra
FIBRAL Antara
Finas Propecia
Finasteride Generic Proscar
FINCAR Proscar
Finpecia (Finasteride)
FINPECIA Propecia
Finsava Propecia
Flagyl Flagyl ER
Flagyl (Metronidazol)
Flarex FML
Flatulence Preventer
FleaDerm
FLEXIDOL Generic Aceclofenac
Flexital Trental SR
FLEXURA GENERIC Metaxalone


|